These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38973685)

  • 1. Recent Surge in Mumps Cases in India: Will the Introduction of the MMR Vaccine Prevent Future Outbreaks?
    Kumar P; Vashishtha VM
    Indian Pediatr; 2024 Jul; 61(7):695. PubMed ID: 38973685
    [No Abstract]   [Full Text] [Related]  

  • 2. Introducing combined measles, mumps and rubella vaccine in Chandigarh, India: issues and concerns.
    Bhatnagar N; Kaur R; Gupta M; Sharma D
    Indian Pediatr; 2014 Jun; 51(6):441-3. PubMed ID: 24986275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-preventable mumps outbreaks in schoolchildren in Catalonia.
    Cardeñosa N; Domínguez A; Camps N; Martínez A; Torner N; Navas E; Salleras L
    Scand J Infect Dis; 2006; 38(8):671-4. PubMed ID: 16857613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania.
    Lazar M; Stănescu A; Penedos AR; Pistol A
    Euro Surveill; 2019 Jul; 24(29):. PubMed ID: 31339098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I; Kontio M; Paunio M; Peltola H
    Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Surge in Mumps Cases in India: Need for Urgent Remedial Measures.
    Abu Bashar MD; Ahmed Khan I; Sridevi G
    Indian Pediatr; 2024 Apr; 61(4):370-374. PubMed ID: 38597102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low vaccine efficacy of mumps component among MMR vaccine recipients in Chennai, India.
    Malaiyan J; Menon T
    Indian J Med Res; 2014 May; 139(5):773-5. PubMed ID: 25027089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An outbreak of mumps in the metropolitan area of Walsall, UK.
    Pugh RN; Akinosi B; Pooransingh S; Kumar J; Grant S; Livesley E; Linnane J; Ramaiah S
    Int J Infect Dis; 2002 Dec; 6(4):283-7. PubMed ID: 12718822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak.
    Ogbuanu IU; Kutty PK; Hudson JM; Blog D; Abedi GR; Goodell S; Lawler J; McLean HQ; Pollock L; Rausch-Phung E; Schulte C; Valure B; Armstrong GL; Gallagher K
    Pediatrics; 2012 Dec; 130(6):e1567-74. PubMed ID: 23129075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notes from the Field: Mumps Outbreak - Alaska, May 2017-July 2018.
    Tiffany A; Shannon D; Mamtchueng W; Castrodale L; McLaughlin J
    MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(33):940-941. PubMed ID: 30138308
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Practices for Measles-Mumps-Rubella Vaccination Among US Pediatric International Travelers.
    Hyle EP; Rao SR; Bangs AC; Gastañaduy P; Fiebelkorn AP; Hagmann SHF; Walker AT; Walensky RP; Ryan ET; LaRocque RC
    JAMA Pediatr; 2020 Feb; 174(2):e194515. PubMed ID: 31816033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City.
    Livingston KA; Rosen JB; Zucker JR; Zimmerman CM
    Vaccine; 2014 Jan; 32(3):369-74. PubMed ID: 24252695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resurgence risk for measles, mumps and rubella in France in 2018 and 2020.
    Béraud G; Abrams S; Beutels P; Dervaux B; Hens N
    Euro Surveill; 2018 Jun; 23(25):. PubMed ID: 29945697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
    Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J
    Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles, mumps, rubella prevention: how can we do better?
    Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
    Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004407. PubMed ID: 32309885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines for measles, mumps and rubella in children.
    Demicheli V; Rivetti A; Debalini MG; Di Pietrantonj C
    Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD004407. PubMed ID: 22336803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control--Guam 2009 to 2010.
    Nelson GE; Aguon A; Valencia E; Oliva R; Guerrero ML; Reyes R; Lizama A; Diras D; Mathew A; Camacho EJ; Monforte MN; Chen TH; Mahamud A; Kutty PK; Hickman C; Bellini WJ; Seward JF; Gallagher K; Fiebelkorn AP
    Pediatr Infect Dis J; 2013 Apr; 32(4):374-80. PubMed ID: 23099425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mumps incidence in Israel--impact of MMR vaccine.
    Slater PE; Roitman M; Costin C
    Public Health Rev; 1990-1991; 18(1):88-93. PubMed ID: 2132885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
    MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.